Evaluation of Hemostasis in Bleeding and Thrombotic Disorders

Description

The objective of this study will be to assess the coagulation system in-vitro in a variety of bleeding and clotting disorders using the ROTEG analyzer and the thrombin generation assay.

Conditions

Blood Coagulation Disorders, Inherited, Thrombotic Disorder

Study Overview

Study Details

Study overview

The objective of this study will be to assess the coagulation system in-vitro in a variety of bleeding and clotting disorders using the ROTEG analyzer and the thrombin generation assay.

Evaluation of Hemostasis in Bleeding and Thrombotic Disorders Using the Roteg Analyzer and the Thrombin Generation Assay

Evaluation of Hemostasis in Bleeding and Thrombotic Disorders

Condition
Blood Coagulation Disorders, Inherited
Intervention / Treatment

-

Contacts and Locations

Houston

The Univerisity of Texas Health Science Center at Houston, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Congenital or Acquired Bleeding Disorder Congenital or Acquired Thrombotic Disorder
  • * Poor venous access

Ages Eligible for Study

1 Day to 98 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

The University of Texas Health Science Center, Houston,

Miguel Escobar, M.D., PRINCIPAL_INVESTIGATOR, The University of Texas Health Science Center, Houston

Study Record Dates

2024-01